Up a level |
Al-Khafaji, ASK, Marcus, MW, Davies, MPA ORCID: 0000-0002-7609-4977, Risk, JM ORCID: 0000-0002-8770-7783, Shaw, RJ ORCID: 0000-0002-5157-4042, Field, JK ORCID: 0000-0003-3951-6365 and Liloglou, T ORCID: 0000-0003-0460-1404
(2017)
AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer.
Oncology letters, 13 (6).
pp. 4463-4468.
Al-Khafaji, AS, Davies, MP ORCID: 0000-0002-7609-4977, Risk, JM ORCID: 0000-0002-8770-7783, Marcus, MW, Koffa, M, Gosney, JR, Shaw, RJ ORCID: 0000-0002-5157-4042, Field, JK ORCID: 0000-0003-3951-6365 and Liloglou, T ORCID: 0000-0003-0460-1404
(2017)
Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
British journal of cancer, 116 (05).
pp. 592-599.
Shaw, RJ ORCID: 0000-0002-5157-4042, Omar, MM, Rokadiya, S, Kogera, FA, Lowe, D, Hall, GL, Woolgar, JA, Homer, J, Liloglou, T ORCID: 0000-0003-0460-1404, Field, JK ORCID: 0000-0003-3951-6365 et al (show 1 more authors)
(2009)
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.
BRITISH JOURNAL OF CANCER, 101 (1).
pp. 139-144.
McRonald, FE, Liloglou, T ORCID: 0000-0003-0460-1404, Xinarianos, G, Hill, L, Rowbottom, L, Langan, JE, Ellis, A, Shaw, JM, Field, JK ORCID: 0000-0003-3951-6365 and Risk, JM ORCID: 0000-0002-8770-7783
(2006)
Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC):: evidence for <i>trans</i>-allele repression.
HUMAN MOLECULAR GENETICS, 15 (8).
pp. 1271-1277.
Borgna, SC, Clarke, PT, Schache, AG ORCID: 0000-0001-9466-6038, Lowe, D, Ho, MW, McCarthy, CE, Adair, S, Field, EA, Field, JK ORCID: 0000-0003-3951-6365, Holt, D et al (show 4 more authors)
(2017)
Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
Head & neck, 39 (10).
pp. 1997-2003.
Cossar, LH, Schache, AG ORCID: 0000-0001-9466-6038, Risk, JM ORCID: 0000-0002-8770-7783, Sacco, JJ, Jones, NJ ORCID: 0000-0003-1801-1456 and Lord, R
(2017)
Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer.
Clinical Oncology, 29 (9).
pp. 626-634.
Okoturo, EM, Risk, JM ORCID: 0000-0002-8770-7783, Schache, AG ORCID: 0000-0001-9466-6038, Shaw, RJ ORCID: 0000-0002-5157-4042 and Boyd, MT ORCID: 0000-0002-2336-2106
(2018)
Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 56 (09).
pp. 780-785.
Schache, AG ORCID: 0000-0001-9466-6038, Hall, G, Woolgar, JA, Nikolaidis, G, Triantafyllou, A, Lowe, D, Risk, JM ORCID: 0000-0002-8770-7783, Shaw, RJ ORCID: 0000-0002-5157-4042 and Liloglou, T ORCID: 0000-0003-0460-1404
(2010)
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.
BRITISH JOURNAL OF CANCER, 103 (12).
pp. 1846-1851.
Ghazali, N, Roe, B, Lowe, D, Tandon, S, Jones, TM, Shaw, RJ ORCID: 0000-0002-5157-4042, Risk, JM ORCID: 0000-0002-8770-7783 and Rogers, SN
(2017)
Using the patients concerns inventory for distress screening in post-treatment head and neck cancer survivors.
Journal of Cranio-Maxillofacial Surgery, 45 (10).
pp. 1743-1748.
Ho, MW, Risk, JM ORCID: 0000-0002-8770-7783, Woolgar, JA, Field, EA, Field, JK ORCID: 0000-0003-3951-6365, Steele, JC, Rajlawat, BP, Triantafyllou, A, Rogers, SN, Lowe, D et al (show 1 more authors)
(2012)
The clinical determinants of malignant transformation in oral epithelial dysplasia.
ORAL ONCOLOGY, 48 (10).
pp. 969-976.
Ho, MW, Risk, JM ORCID: 0000-0002-8770-7783, Woolgar, JA, Field, EA, Field, JK ORCID: 0000-0003-3951-6365, Steele, JC, Rajlawat, BP, Triantafyllou, A, Rogers, SN, Lowe, D et al (show 1 more authors)
(2012)
The clinical determinants of malignant transformation in oral epithelial dysplasia.
ORAL ONCOLOGY, 48 (10).
969 - 976.
Jithesh, PV, Risk, JM ORCID: 0000-0002-8770-7783, Schache, AG ORCID: 0000-0001-9466-6038, Dhanda, J, Lane, B, Liloglou, T ORCID: 0000-0003-0460-1404 and Shaw, RJ ORCID: 0000-0002-5157-4042
(2013)
The epigenetic landscape of oral squamous cell carcinoma.
BRITISH JOURNAL OF CANCER, 108 (2).
pp. 370-379.
Shahabi, M, Daloii, MRN, Langan, JE, Rowbottom, L, Jahanzad, E, Khoshbin, E, Taghikhani, M, Field, JK ORCID: 0000-0003-3951-6365 and Risk, JM ORCID: 0000-0002-8770-7783
(2004)
An investigation of the tylosis with oesophageal cancer (<i>TOC</i>) locus in Iranian patients with oesophageal squamous cell carcinoma.
INTERNATIONAL JOURNAL OF ONCOLOGY, 25 (2).
pp. 389-395.